NCT04399733 is a clinical trial in COVID-19, SARS-CoV 2 Infection, sponsored by Future Genetics Limited.

Who is sponsoring NCT04399733?

NCT04399733 is sponsored by Future Genetics Limited.

What condition does NCT04399733 study?

NCT04399733 studies COVID-19, SARS-CoV 2 Infection, Health Disparities.

Is NCT04399733 still recruiting?

NCT04399733 is currently withdrawn. Last updated 26 August 2021.

Last reviewed 2021-08-26 · How we verify

NCT04399733

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

EMPOWER - BAME vs COVID

Withdrawn Last updated 26 August 2021

What this trial tests

trial in COVID-19, SARS-CoV 2 Infection. Withdrawn.

Timeline

1 February 2021

Primary endpoint
1 February 2023

1 February 2024

Quick facts

Lead sponsor	Future Genetics Limited
Status	Withdrawn
Study type	OBSERVATIONAL
Start date	1 February 2021
Primary completion	1 February 2023
Estimated completion	1 February 2024
Sites	1 location across United Kingdom

Conditions studied

COVID-19, SARS-CoV 2 Infection — all drugs for COVID-19, SARS-CoV 2 Infection →
Health Disparities — all drugs for Health Disparities →

Sponsor

Future Genetics Limited

Who can join

6 and older, any sex, with COVID-19, SARS-CoV 2 Infection or Health Disparities. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The COVID-19 virus pandemic has massively affected us all. Moreover, there is a disproportionately high number of COVID-19 severe infections and deaths in British Black, Asian and minority ethnic (BAME) patients. This clinical study plans to discover new ways of protecting people from this virus by looking at our DNA and biology.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Future Genetics Limited trials

Trials by the same sponsor.

NCT03987633 — EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04399733 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Future Genetics Limited
Last refreshed: 26 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04399733.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing